| Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
|
SPS1/STE20-related protein kinase YSK4 (YSK4)
|
|
32.090 (86/268) |
3.64E-34 |
|
Serine/threonine-protein kinase Nek5 (NEK5)
|
|
28.571 (76/266) |
2.60E-26 |
|
Serine/threonine-protein kinase Nek11 (NEK11)
|
|
27.715 (74/267) |
1.41E-25 |
|
Serine/threonine-protein kinase 33 (STK33)
|
|
32.524 (67/206) |
2.17E-25 |
|
NIMA-related kinase 6 (NEK6)
|
|
29.245 (93/318) |
3.19E-25 |
|
NIMA-related kinase 7 (NEK7)
|
|
30.515 (83/272) |
4.37E-25 |
|
Serine/threonine-protein kinase Nek4 (NEK4)
|
|
28.986 (80/276) |
5.09E-25 |
|
Serine/threonine-protein kinase WNK4 (WNK4)
|
|
32.889 (74/225) |
5.70E-25 |
|
MAPK/ERK kinase kinase 1 (MAP3K1)
|
|
29.699 (79/266) |
3.12E-24 |
|
PAK-1 protein kinase (PAK1)
|
|
29.880 (75/251) |
4.00E-24 |
|
Serine/threonine-protein kinase PAK 3 (PAK3)
|
|
30.279 (76/251) |
4.06E-24 |
|
Serine/threonine-protein kinase 25 (STK25)
|
|
29.502 (77/261) |
5.25E-24 |
|
Serine/threonine-protein kinase ULK1 (ULK1)
|
|
32.479 (76/234) |
5.56E-24 |
|
PAK-2 protein kinase (PAK2)
|
|
29.880 (75/251) |
7.26E-24 |
|
STE20-related serine/threonine-protein kinase (SLK)
|
|
30.350 (78/257) |
9.94E-24 |
|
Serine/threonine-protein kinase ULK2 (ULK2)
|
|
32.870 (71/216) |
1.09E-23 |
|
Apoptosis signal-regulating kinase 2 (MAP3K6)
|
|
28.710 (89/310) |
1.47E-23 |
|
SNF-related serine/threonine-protein kinase (SNRK)
|
|
25.217 (87/345) |
1.67E-23 |
|
Leucine-rich repeat serine/threonine-protein kinase 1 (LRRK1)
|
|
31.613 (98/310) |
2.24E-23 |
|
WNK lysine-deficient protein kinase 3 (WNK3)
|
|
32.787 (80/244) |
2.76E-23 |
|
MAPK/ERK kinase kinase 4 (MAP3K4)
|
|
28.906 (74/256) |
3.01E-23 |
|
Leucine-rich repeat kinase 2 (LRRK2)
|
|
31.230 (99/317) |
3.08E-23 |
|
Myosin light chain kinase 3 (MYLK3)
|
|
32.895 (75/228) |
3.56E-23 |
|
Serine/threonine-protein kinase 24 (STK24)
|
|
27.612 (74/268) |
4.22E-23 |
|
Serine/threonine-protein kinase Nek3 (NEK3)
|
|
28.137 (74/263) |
4.89E-23 |
|
Serine/threonine-protein kinase PAK 5 (PAK5)
|
|
31.863 (65/204) |
6.51E-23 |
|
Serine/threonine-protein kinase WNK2 (WNK2)
|
|
32.579 (72/221) |
7.55E-23 |
|
Serine/threonine-protein kinase WNK1 (WNK1)
|
|
32.579 (72/221) |
1.17E-22 |
|
Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)
|
|
28.477 (86/302) |
1.37E-22 |
|
PKC-delta-interacting protein kinase (RIPK4)
|
|
30.272 (89/294) |
1.45E-22 |
|
Serine/threonine-protein kinase MARK2 (MARK2)
|
|
29.811 (79/265) |
1.52E-22 |
|
MAPK/ERK kinase kinase 3 (MAP3K3)
|
|
32.099 (78/243) |
1.70E-22 |
|
Serine/threonine-protein kinase 26 (STK26)
|
|
27.027 (80/296) |
2.01E-22 |
|
RAC-alpha serine/threonine-protein kinase (AKT1)
|
|
28.346 (72/254) |
2.01E-22 |
|
MAPK/ERK kinase kinase 2 (MAP3K2)
|
|
32.189 (75/233) |
2.93E-22 |
|
Omphalocele kinase 1 (NUAK1)
|
|
30.876 (67/217) |
3.16E-22 |
|
Serine/threonine-protein kinase PAK 6 (PAK6)
|
|
31.863 (65/204) |
3.31E-22 |
|
Ribosomal protein S6 kinase alpha-1 (RSK1)
|
|
31.330 (73/233) |
3.64E-22 |
|
Serine/threonine-protein kinase MARK1 (MARK1)
|
|
32.075 (68/212) |
9.15E-22 |
|
Serine/threonine-protein kinase TAO2 (TAOK2)
|
|
31.835 (85/267) |
1.49E-21 |
|
Apoptosis signal-regulating kinase 1 (MAP3K5)
|
|
29.688 (76/256) |
1.54E-21 |
|
Protein kinase D (PRKD1)
|
|
32.075 (68/212) |
1.62E-21 |
|
Microtubule affinity regulating kinase 3 (MARK3)
|
|
29.388 (72/245) |
2.13E-21 |
|
Mitogen-activated protein kinase kinase kinase 15 (MAP3K15)
|
|
28.244 (74/262) |
3.20E-21 |
|
NIMA-related kinase 1 (NEK1)
|
|
25.279 (68/269) |
3.74E-21 |
|
Calcium/calmodulin-dependent protein kinase type 1G (CAMK1G)
|
|
32.367 (67/207) |
3.80E-21 |
|
Serine/threonine-protein kinase 10 (STK10)
|
|
29.008 (76/262) |
3.87E-21 |
|
ERK activator kinase 5 (MAP2K5)
|
|
28.897 (76/263) |
4.78E-21 |
|
Ribosomal protein S6 kinase alpha-3 (RSK3)
|
|
31.667 (76/240) |
8.81E-21 |
|
Myosin light chain kinase 2 (MYLK2)
|
|
30.841 (66/214) |
9.08E-21 |
|
Ribosomal protein S6 kinase alpha-2 (RSK2)
|
|
31.330 (73/233) |
9.41E-21 |
|
RAC-beta serine/threonine-protein kinase (AKT2)
|
|
27.500 (66/240) |
1.03E-20 |
|
Serine/threonine-protein kinase D3 (PRKD3)
|
|
31.163 (67/215) |
1.11E-20 |
|
TAO kinase 1 (TAOK1)
|
|
30.189 (80/265) |
1.14E-20 |
|
Unc-51 like kinase 3 (ULK3)
|
|
27.969 (73/261) |
1.34E-20 |
|
NUAK family SNF1-like kinase 2 (NUAK2)
|
|
30.189 (64/212) |
1.44E-20 |
|
Protein kinase C beta (PRKCB)
|
|
33.054 (79/239) |
1.51E-20 |
|
MAP/microtubule affinity-regulating kinase 4 (MARK4)
|
|
28.906 (74/256) |
1.64E-20 |
|
RAC-gamma serine/threonine-protein kinase (AKT3)
|
|
27.119 (64/236) |
1.86E-20 |
|
cAMP-dependent protein kinase catalytic subunit gamma (PRKACG)
|
|
29.804 (76/255) |
2.19E-20 |
|
PAK-4 protein kinase (PAK4)
|
|
30.882 (63/204) |
3.06E-20 |
|
Serine/threonine-protein kinase D2 (PRKD2)
|
|
32.075 (68/212) |
3.28E-20 |
|
Polo-like kinase 4 (PLK4)
|
|
27.985 (75/268) |
3.90E-20 |
|
Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
|
|
32.883 (73/222) |
3.98E-20 |
|
Beta-adrenergic receptor kinase 2 (ADRBK2)
|
|
27.734 (71/256) |
5.03E-20 |
|
ERK activator kinase 2 (MEK2)
|
|
30.000 (60/200) |
5.27E-20 |
|
Protein kinase C gamma (PRKCG)
|
|
30.894 (76/246) |
7.42E-20 |
|
Myosin light chain kinase family member 4 (MYLK4)
|
|
31.776 (68/214) |
7.50E-20 |
|
MST-1 protein kinase (STK4)
|
|
26.054 (68/261) |
7.60E-20 |
|
Aurora kinase A (AURKA)
|
|
26.378 (67/254) |
8.19E-20 |
|
Serine/threonine-protein kinase Nek8 (NEK8)
|
|
26.054 (68/261) |
1.45E-19 |
|
Ste-20-related kinase (STK39)
|
|
27.113 (77/284) |
1.57E-19 |
|
IL-1 receptor-associated kinase 1 (IRAK1)
|
|
29.464 (66/224) |
1.87E-19 |
|
Oxidative stress responsive 1 (OXSR1)
|
|
26.531 (78/294) |
1.93E-19 |
|
Hormonally up-regulated neu tumor-associated kinase (HUNK)
|
|
27.413 (71/259) |
2.31E-19 |
|
Protein kinase G2 (PRKG2)
|
|
32.271 (81/251) |
2.76E-19 |
|
ERK activator kinase 1 (MEK1)
|
|
28.000 (56/200) |
3.38E-19 |
|
Protein kinase C theta (PRKCQ)
|
|
28.692 (68/237) |
3.60E-19 |
|
Protein kinase C alpha (PRKCA)
|
|
29.707 (71/239) |
5.20E-19 |
|
Serine/threonine-protein kinase Sgk2 (SGK2)
|
|
29.487 (69/234) |
5.26E-19 |
|
Cyclin-dependent kinase 3 (CDK3)
|
|
31.839 (71/223) |
5.50E-19 |
|
Serine/threonine-protein kinase 3 (STK3)
|
|
25.670 (67/261) |
5.91E-19 |
|
MEK kinase kinase 1 (MAP4K1)
|
|
27.632 (63/228) |
6.19E-19 |
|
Serine/threonine-protein kinase Nek9 (NEK9)
|
|
24.815 (67/270) |
6.88E-19 |
|
Myosin light kinase (MYLK)
|
|
28.505 (61/214) |
9.33E-19 |
|
Polo-like kinase 2 (PLK2)
|
|
26.255 (68/259) |
9.60E-19 |
|
Proto-oncogene serine/threonine-protein kinase mos (MOS)
|
|
25.574 (78/305) |
9.80E-19 |
|
Ribosomal protein S6 kinase alpha-6 (RSK6)
|
|
30.380 (72/237) |
1.08E-18 |
|
MEK kinase kinase 3 (MAP4K3)
|
|
30.594 (67/219) |
1.29E-18 |
|
TAO kinase 3 (TAOK3)
|
|
30.769 (80/260) |
1.31E-18 |
|
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G)
|
|
26.619 (74/278) |
1.32E-18 |
|
Beta-adrenergic receptor kinase 1 (ADRBK1)
|
|
26.953 (69/256) |
1.46E-18 |
|
BR serine/threonine kinase 1 (BRSK1)
|
|
26.519 (96/362) |
1.66E-18 |
|
TRAF2 and NCK interacting kinase (TNIK)
|
|
25.632 (71/277) |
1.68E-18 |
|
cAMP-dependent protein kinase catalytic subunit beta (PRKACB)
|
|
28.261 (65/230) |
1.78E-18 |
|
Myosin-IIIb (MYO3B)
|
|
28.881 (80/277) |
1.93E-18 |
|
Calcium/calmodulin-dependent protein kinase type II subunit beta (CAMK2B)
|
|
27.500 (77/280) |
2.12E-18 |
|
Serine/threonine-protein kinase Nek10 (NEK10)
|
|
26.316 (70/266) |
2.35E-18 |
|
Calcium/calmodulin-dependent protein kinase type 1B (PNCK)
|
|
31.250 (65/208) |
2.82E-18 |
|
Protein kinase C delta (PRKCD)
|
|
31.308 (67/214) |
3.03E-18 |
|
Microtubule-associated serine/threonine-protein kinase 4 (MAST4)
|
|
27.572 (67/243) |
3.68E-18 |
|
Serine/threonine-protein kinase Sgk1 (SGK1)
|
|
31.064 (73/235) |
3.95E-18 |
|
Serine/threonine-protein kinase tousled-like 2 (TLK2)
|
|
30.233 (65/215) |
5.16E-18 |
|
Calcium/calmodulin-dependent protein kinase type 1D (CAMK1D)
|
|
32.075 (68/212) |
5.57E-18 |
|
cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)
|
|
28.936 (68/235) |
5.83E-18 |
|
Protein kinase N1 (PKN1)
|
|
28.926 (70/242) |
6.03E-18 |
|
Ribosomal protein S6 kinase alpha-4 (RPS6KA4)
|
|
30.531 (69/226) |
6.28E-18 |
|
Serine/threonine-protein kinase PLK3 (PLK3)
|
|
27.519 (71/258) |
7.01E-18 |
|
Serine/threonine-protein kinase NIM1 (NIM1K)
|
|
27.523 (90/327) |
7.28E-18 |
|
Calmodulin-dependent kinase II (CAMKK2)
|
|
28.837 (62/215) |
8.84E-18 |
|
Serine/threonine-protein kinase Sgk3 (SGK3)
|
|
29.114 (69/237) |
1.13E-17 |
|
Microtubule-associated serine/threonine-protein kinase 2 (MAST2)
|
|
28.270 (67/237) |
1.24E-17 |
|
Testis-specific serine/threonine-protein kinase 3 (TSSK3)
|
|
30.268 (79/261) |
1.37E-17 |
|
Ribosomal protein S6 kinase beta-1 (S6K1)
|
|
28.455 (70/246) |
1.41E-17 |
|
Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5)
|
|
29.825 (68/228) |
1.47E-17 |
|
Serine/threonine-protein kinase tousled-like 1 (TLK1)
|
|
29.907 (64/214) |
1.60E-17 |
|
Microtubule-associated serine/threonine-protein kinase 1 (MAST1)
|
|
28.511 (67/235) |
1.62E-17 |
|
Cyclin-dependent kinase 11B (CDK11B)
|
|
30.453 (74/243) |
1.63E-17 |
|
Protein kinase C zeta (PRKCZ)
|
|
27.706 (64/231) |
1.66E-17 |
|
Cyclin-dependent kinase-like 5 (CDKL5)
|
|
28.631 (69/241) |
1.82E-17 |
|
Ribosomal protein S6 kinase beta-2 (RPS6KB2)
|
|
27.686 (67/242) |
1.94E-17 |
|
Doublecortin-like kinase 1 (DCLK1)
|
|
28.516 (73/256) |
1.96E-17 |
|
Fused homolog (STK36)
|
|
27.132 (70/258) |
1.97E-17 |
|
Cyclin-dependent kinase 11A (CDK11A)
|
|
27.907 (84/301) |
2.51E-17 |
|
Myosin-IIIa (MYO3A)
|
|
27.575 (83/301) |
2.82E-17 |
|
Serine/threonine-protein kinase Chk2 (RAD53)
|
|
27.813 (89/320) |
2.84E-17 |
|
Ribosomal protein S6 kinase alpha-5 (RSK5)
|
|
29.075 (66/227) |
3.04E-17 |
|
BR serine/threonine kinase 2 (BRSK2)
|
|
25.113 (111/442) |
3.10E-17 |
|
PDZ binding kinase (PBK)
|
|
24.901 (63/253) |
4.39E-17 |
|
Microtubule-associated serine/threonine-protein kinase 3 (MAST3)
|
|
28.936 (68/235) |
5.02E-17 |
|
Protein kinase N2 (PKN2)
|
|
31.132 (66/212) |
5.91E-17 |
|
Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A)
|
|
30.093 (65/216) |
6.39E-17 |
|
Calcium/calmodulin-dependent protein kinase type II subunit delta (CAMK2D)
|
|
30.556 (66/216) |
6.42E-17 |
|
Death-associated protein kinase 3 (DAPK3)
|
|
29.187 (61/209) |
6.56E-17 |
|
cAMP-dependent protein kinase catalytic subunit PRKX (PRKX)
|
|
28.346 (72/254) |
6.58E-17 |
|
Doublecortin-like kinase 3 (DCLK3)
|
|
27.094 (55/203) |
7.26E-17 |
|
Calcium/calmodulin-dependent protein kinase type 1 (CAMK1)
|
|
31.308 (67/214) |
9.89E-17 |
|
Serine/threonine-protein kinase H1 (PSKH1)
|
|
30.093 (65/216) |
1.02E-16 |
|
Salt-inducible kinase 2 (SIK2)
|
|
28.899 (63/218) |
1.21E-16 |
|
Protein kinase C eta type (PRKCH)
|
|
28.070 (64/228) |
1.46E-16 |
|
Protein kinase C epsilon (PRKCE)
|
|
30.415 (66/217) |
1.56E-16 |
|
Misshapen-like kinase 1 (MINK1)
|
|
24.910 (69/277) |
1.87E-16 |
|
Protein kinase C iota (PRKCI)
|
|
26.809 (63/235) |
1.95E-16 |
|
Polo-like kinase 1 (PLK1)
|
|
26.996 (71/263) |
2.05E-16 |
|
Inhibitor of nuclear factor kappa-B kinase alpha (IKKA)
|
|
28.378 (63/222) |
2.50E-16 |
|
Salt-inducible kinase 1 (SIK1)
|
|
27.232 (61/224) |
2.63E-16 |
|
Putative serine/threonine-protein kinase SIK1B (SIK1B)
|
|
27.232 (61/224) |
2.68E-16 |
|
MEK kinase kinase 2 (MAP4K2)
|
|
30.806 (65/211) |
3.53E-16 |
|
Maternal embryonic leucine zipper kinase (MELK)
|
|
27.509 (74/269) |
3.96E-16 |
|
Death-associated protein kinase 2 (DAPK2)
|
|
26.840 (62/231) |
3.97E-16 |
|
5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
|
|
31.579 (66/209) |
5.44E-16 |
|
IL-1 receptor-associated kinase 3 (IRAK3)
|
|
26.728 (58/217) |
5.67E-16 |
|
Adaptor-associated kinase 1 (AAK1)
|
|
24.823 (70/282) |
6.25E-16 |
|
Mitogen-activated protein kinase 13 (MAPK13)
|
|
29.630 (64/216) |
7.21E-16 |
|
Striated muscle preferentially expressed protein kinase (SPEG)
|
|
29.944 (53/177) |
8.65E-16 |
|
5'-AMP-activated protein kinase catalytic subunit alpha-2 (PRKAA2)
|
|
31.280 (66/211) |
1.06E-15 |
|
Calcium/calmodulin-dependent protein kinase type IV (CAMK4)
|
|
28.571 (60/210) |
1.09E-15 |
|
NIMA-related kinase 2 (NEK2)
|
|
25.513 (87/341) |
1.46E-15 |
|
Tyrosine-protein kinase EIF2AK2 (p68)
|
|
25.407 (78/307) |
1.88E-15 |
|
Stress-activated protein kinase 2a (p38 alpha)
|
|
27.536 (57/207) |
1.95E-15 |
|
Cyclin-dependent kinase 2 (CDK2)
|
|
29.911 (67/224) |
2.33E-15 |
|
Putative 3-phosphoinositide-dependent protein kinase 2 (PDPK2P)
|
|
28.054 (62/221) |
2.54E-15 |
|
Peripheral plasma membrane protein CASK (CASK)
|
|
30.233 (65/215) |
2.55E-15 |
|
Putative serine/threonine-protein kinase PRKY (PRKY)
|
|
27.556 (62/225) |
2.60E-15 |
|
CaM-kinase IV kinase (CAMKK1)
|
|
28.372 (61/215) |
2.99E-15 |
|
Doublecortin-like kinase 2 (DCLK2)
|
|
26.493 (71/268) |
3.39E-15 |
|
Testis-specific serine/threonine-protein kinase 4 (TSSK4)
|
|
26.820 (70/261) |
3.85E-15 |
|
Death-associated protein kinase 1 (DAPK1)
|
|
30.769 (52/169) |
4.83E-15 |
|
Protein kinase N3 (PKN3)
|
|
30.144 (63/209) |
5.18E-15 |
|
TGF-beta receptor type I (TGFBR1)
|
|
28.173 (91/323) |
7.06E-15 |
|
Phosphoinositide dependent protein kinase-1 (PDPK1)
|
|
28.054 (62/221) |
7.32E-15 |
|
Serine/threonine-protein kinase 35 (STK35)
|
|
25.893 (87/336) |
7.72E-15 |
|
Cyclin-dependent kinase 16 (CDK16)
|
|
31.455 (67/213) |
9.11E-15 |
|
Aurora kinase C (AURKC)
|
|
26.667 (60/225) |
9.97E-15 |
|
Cyclin-dependent kinase 4 (CDK4)
|
|
29.384 (62/211) |
1.13E-14 |
|
Cyclin-dependent kinase 15 (CDK15)
|
|
29.004 (67/231) |
1.17E-14 |
|
Cyclin-dependent kinase 17 (CDK17)
|
|
31.707 (65/205) |
1.20E-14 |
|
Protein kinase G1 (PRKG1)
|
|
24.643 (69/280) |
1.32E-14 |
|
Extracellular signal-regulated kinase 5 (ERK5)
|
|
27.928 (62/222) |
1.34E-14 |
|
Serine/threonine-protein kinase 17B (STK17B)
|
|
29.126 (60/206) |
2.81E-14 |
|
Serine/threonine-protein kinase MRCK beta (CDC42BPB)
|
|
27.969 (73/261) |
3.04E-14 |
|
Cyclin-dependent kinase-like 1 (CDKL1)
|
|
30.693 (62/202) |
3.85E-14 |
|
MEK kinase kinase 4 (MAP4K4)
|
|
26.360 (63/239) |
4.24E-14 |
|
Activin receptor type IB (ACVR1B)
|
|
30.631 (68/222) |
4.45E-14 |
|
Checkpoint kinase-1 (CHK1)
|
|
30.769 (68/221) |
4.71E-14 |
|
MAPK-activated protein kinase 3 (MAPKAPK3)
|
|
26.689 (79/296) |
5.01E-14 |
|
Cyclin-dependent kinase 18 (CDK18)
|
|
32.020 (65/203) |
5.24E-14 |
|
SIK family kinase 3 (SIK3)
|
|
26.147 (57/218) |
6.03E-14 |
|
Cytoplasmic DRAK1 (STK17A)
|
|
30.097 (62/206) |
6.75E-14 |
|
Serine/threonine-protein kinase 32A (STK32A)
|
|
26.316 (70/266) |
7.09E-14 |
|
Cyclin-dependent kinase 10 (CDK10)
|
|
34.975 (71/203) |
7.30E-14 |
|
MAP kinase p38 (MAPK12)
|
|
28.704 (62/216) |
7.32E-14 |
|
Cyclin-dependent kinase 6 (CDK6)
|
|
29.327 (61/208) |
7.50E-14 |
|
MAP kinase signal-integrating kinase 2 (MKNK2)
|
|
30.973 (70/226) |
8.05E-14 |
|
Obscurin (OBSCN)
|
|
29.245 (62/212) |
8.14E-14 |
|
Testis-specific serine/threonine-protein kinase 6 (TSSK6)
|
|
27.632 (63/228) |
8.19E-14 |
|
BMP-2-inducible protein kinase (BMP2K)
|
|
26.354 (73/277) |
8.39E-14 |
|
Rho-associated protein kinase 1 (ROCK1)
|
|
25.342 (74/292) |
9.29E-14 |
|
Cyclin-dependent kinase 1 (CDK1)
|
|
28.311 (62/219) |
9.35E-14 |
|
Cyclin-dependent kinase 14 (CDK14)
|
|
30.374 (65/214) |
1.05E-13 |
|
Rho-associated protein kinase 2 (ROCK2)
|
|
26.400 (66/250) |
1.22E-13 |
|
Activin receptor type IIB (ACVR2B)
|
|
27.244 (85/312) |
1.26E-13 |
|
ERK activator kinase 7 (MAP2K7)
|
|
26.449 (73/276) |
1.49E-13 |
|
MAPK-activated protein kinase 2 (MAPKAPK2)
|
|
24.176 (88/364) |
1.51E-13 |
|
Serine/threonine-protein kinase NLK (NLK)
|
|
31.308 (67/214) |
1.84E-13 |
|
Nik-related protein kinase (NRK)
|
|
25.338 (75/296) |
2.28E-13 |
|
Serine/threonine-protein kinase MAK (MAK)
|
|
28.643 (57/199) |
2.29E-13 |
|
Triple functional domain protein (TRIO)
|
|
27.953 (71/254) |
2.43E-13 |
|
Serine/threonine-protein kinase ICK (CILK1)
|
|
26.500 (53/200) |
2.88E-13 |
|
Serine/threonine-protein kinase H2 (PSKH2)
|
|
29.048 (61/210) |
3.54E-13 |
|
Yet another novel kinase 2 (STK32B)
|
|
26.692 (71/266) |
4.13E-13 |
|
Glycogen synthase kinase-3 beta (GSK-3B)
|
|
29.646 (67/226) |
4.69E-13 |
|
Extracellular signal-regulated kinase 1 (ERK1)
|
|
25.962 (54/208) |
5.13E-13 |
|
Serine/threonine-protein kinase PDIK1L (PDIK1L)
|
|
25.506 (63/247) |
5.14E-13 |
|
Ribosomal protein S6 kinase-related protein (RSKR)
|
|
29.060 (68/234) |
5.86E-13 |
|
Cyclin-dependent kinase 13 (CDK13)
|
|
27.876 (63/226) |
6.86E-13 |
|
Cyclin-dependent kinase-like 2 (CDKL2)
|
|
25.248 (51/202) |
1.02E-12 |
|
Activin receptor type IIA (ACVR2A)
|
|
27.517 (82/298) |
1.02E-12 |
|
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE)
|
|
30.000 (66/220) |
1.09E-12 |
|
Anti-mullerian hormone II receptor (AMHR2)
|
|
28.440 (93/327) |
1.10E-12 |
|
Serine/threonine-protein kinase ULK4 (ULK4)
|
|
26.690 (75/281) |
1.14E-12 |
|
Dual specificity protein kinase TTK (MPS1)
|
|
24.809 (65/262) |
1.58E-12 |
|
G protein-coupled receptor kinase 6 (GRK6)
|
|
27.619 (58/210) |
1.77E-12 |
|
Cyclin-dependent kinase 12 (CDK12)
|
|
27.103 (58/214) |
1.78E-12 |
|
Stress-activated protein kinase 2b (p38 beta)
|
|
28.095 (59/210) |
1.79E-12 |
|
Cyclin-dependent kinase-like 3 (CDKL3)
|
|
26.540 (56/211) |
3.23E-12 |
|
Serine/threonine-protein kinase 32C (STK32C)
|
|
26.786 (60/224) |
3.85E-12 |
|
Cyclin-dependent kinase 19 (CDK19)
|
|
27.679 (62/224) |
4.02E-12 |
|
Cyclin-G-associated kinase (GAK)
|
|
24.080 (72/299) |
4.77E-12 |
|
Glycogen synthase kinase-3 alpha (GSK-3A)
|
|
28.571 (64/224) |
5.45E-12 |
|
Serine/threonine-protein kinase MRCK gamma (CDC42BPG)
|
|
25.214 (59/234) |
5.46E-12 |
|
Extracellular signal-regulated kinase 2 (ERK2)
|
|
25.728 (53/206) |
7.97E-12 |
|
Serine/threonine-protein kinase cot (COT)
|
|
27.308 (71/260) |
1.17E-11 |
|
G protein-coupled receptor kinase 5 (GRK5)
|
|
26.570 (55/207) |
1.18E-11 |
|
Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3)
|
|
26.957 (62/230) |
1.25E-11 |
|
Rhodopsin kinase GRK7 (GRK7)
|
|
28.313 (47/166) |
1.39E-11 |
|
Mitogen-activated protein kinase 6 (MAPK6)
|
|
26.457 (59/223) |
1.55E-11 |
|
Phosphorylase kinase testis gamma 2 (PHKG2)
|
|
27.523 (60/218) |
1.75E-11 |
|
Cyclin-dependent kinase 5 (CDK5)
|
|
30.476 (64/210) |
1.76E-11 |
|
Aurora kinase B (AURKB)
|
|
24.797 (61/246) |
2.03E-11 |
|
Wee1-like protein kinase 2 (WEE2)
|
|
22.642 (72/318) |
2.09E-11 |
|
Testis-specific serine kinase 2 (TSSK2)
|
|
23.019 (61/265) |
2.30E-11 |
|
Cyclin-dependent kinase 7 (CDK7)
|
|
27.962 (59/211) |
2.34E-11 |
|
Testis-specific serine/threonine-protein kinase 1 (TSSK1B)
|
|
23.792 (64/269) |
2.46E-11 |
|
G protein-coupled receptor kinase 4 (GRK4)
|
|
26.923 (56/208) |
2.68E-11 |
|
Cyclin-dependent kinase 9 (CDK9)
|
|
31.977 (55/172) |
2.80E-11 |
|
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4)
|
|
24.727 (68/275) |
3.03E-11 |
|
Bone morphogenetic protein receptor (BMPR2)
|
|
25.957 (61/235) |
3.07E-11 |
|
Cyclin-dependent kinase-like 4 (CDKL4)
|
|
29.612 (61/206) |
4.15E-11 |
|
CaM kinase-like vesicle-associated protein (CAMKV)
|
|
26.708 (43/161) |
5.14E-11 |
|
Mitogen-activated protein kinase 4 (MAPK4)
|
|
28.767 (63/219) |
5.41E-11 |
|
Mitogen-activated protein kinase 15 (MAPK15)
|
|
29.302 (63/215) |
1.30E-10 |
|
Serine/threonine-protein kinase greatwall (MASTL)
|
|
31.875 (51/160) |
1.61E-10 |
|
Stress-activated protein kinase JNK2 (JNK2)
|
|
28.972 (62/214) |
1.67E-10 |
|
CDC42 binding protein kinase alpha (DMPK-like alpha)
|
|
26.068 (61/234) |
1.95E-10 |
|
Citron Rho-interacting kinase (CIT)
|
|
24.390 (80/328) |
2.05E-10 |
|
Serine/threonine-protein kinase LATS1 (LATS1)
|
|
22.559 (67/297) |
2.05E-10 |
|
Cyclin-dependent kinase 8 (CDK8)
|
|
27.442 (59/215) |
2.20E-10 |
|
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A)
|
|
27.830 (59/212) |
3.03E-10 |
|
Serine/threonine-protein kinase NIK (MAP3K14)
|
|
28.241 (61/216) |
3.11E-10 |
|
Wee1-like protein kinase (WEE1)
|
|
24.510 (75/306) |
3.85E-10 |
|
SH3 domain-containing protein 21 (SH3D21)
|
|
48.387 (30/62) |
4.09E-10 |
|
TGF-beta-stimulated factor 1 (STK16)
|
|
24.648 (70/284) |
5.67E-10 |
|
Titin (TTN)
|
23.585 (50/212) |
6.20E-10 |
|
Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B)
|
|
27.143 (57/210) |
6.54E-10 |
|
Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2)
|
|
24.889 (56/225) |
8.27E-10 |
|
NF-kappa-B-activating kinase (TBK1)
|
|
27.027 (60/222) |
9.55E-10 |
|
Large tumor suppressor homolog 2 (LATS2)
|
|
23.922 (61/255) |
1.17E-09 |
|
Serine/threonine-protein kinase pim-1 (PIM1)
|
|
26.182 (72/275) |
1.23E-09 |
|
Serine/threonine-protein kinase SBK1 (SBK1)
|
|
25.234 (54/214) |
1.36E-09 |
|
Kalirin (KALRN)
|
|
26.071 (73/280) |
1.44E-09 |
|
Stress-activated protein kinase JNK1 (JNK1)
|
|
27.500 (66/240) |
2.86E-09 |
|
PAS domain-containing serine/threonine-protein kinase (PASK)
|
|
27.778 (60/216) |
3.07E-09 |
|
Rhodopsin kinase GRK1 (GRK1)
|
|
25.714 (54/210) |
3.20E-09 |
|
PIM-3 protein kinase (PIM3)
|
|
27.542 (65/236) |
3.21E-09 |
|
CDC-like kinase 4 (CLK4)
|
|
25.692 (65/253) |
3.72E-09 |
|
MAPK/MAK/MRK overlapping kinase (MOK)
|
|
26.368 (53/201) |
3.86E-09 |
|
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6)
|
|
30.496 (43/141) |
4.99E-09 |
|
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHKG1)
|
|
28.571 (46/161) |
5.08E-09 |
|
Stress-activated protein kinase JNK3 (JNK3)
|
|
28.641 (59/206) |
6.88E-09 |
|
Tau-tubulin kinase (TTBK1)
|
|
23.358 (64/274) |
6.93E-09 |
|
Serine/threonine-protein kinase pim-2 (PIM2)
|
|
23.759 (67/282) |
9.73E-09 |
|
Eukaryotic translation initiation factor 2-alpha kinase 1 (EIF2AK1)
|
|
29.381 (57/194) |
1.08E-08 |
|
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)
|
|
30.496 (43/141) |
1.13E-08 |
|
CDC-like kinase 1 (CLK1)
|
|
26.522 (61/230) |
2.01E-08 |
|
CDC-like kinase 3 (CLK3)
|
|
25.726 (62/241) |
2.52E-08 |
|
Homeodomain-interacting protein kinase 3 (HIPK3)
|
|
24.576 (58/236) |
2.73E-08 |
|
Serine/threonine-protein kinase PRP4 homolog (PRPF4B)
|
|
26.887 (57/212) |
3.51E-08 |
|
Serine/threonine-protein kinase/endoribonuclease IRE2 (ERN2)
|
|
29.108 (62/213) |
3.98E-08 |
|
STE20-related kinase adapter protein alpha (STRADA)
|
|
24.365 (48/197) |
6.42E-08 |
|
Jouberin (AHI1)
|
|
39.344 (24/61) |
1.33E-07 |
|
Casein kinase I gamma-1 (CSNK1G1)
|
|
26.909 (74/275) |
1.45E-07 |
|
PRKR-like endoplasmic reticulum kinase (PERK)
|
|
29.252 (43/147) |
1.58E-07 |
|
STE20-related kinase adapter protein beta (STRADB)
|
|
23.605 (55/233) |
1.59E-07 |
|
MAPK-activated protein kinase 5 (MAPKAPK5)
|
|
27.374 (49/179) |
1.80E-07 |
|
Serine/threonine kinase-like domain-containing protein STKLD1 (STKLD1)
|
|
30.370 (41/135) |
2.33E-07 |
|
Signal transducing adapter molecule 1 (STAM)
|
|
34.940 (29/83) |
3.98E-07 |
|
Dual-specificity tyrosine-phosphorylation regulated kinase 4 (DYRK4)
|
|
23.256 (50/215) |
4.16E-07 |
|
Interleukin-1 receptor-associated kinase-like 2 (IRAK2)
|
|
23.500 (47/200) |
5.78E-07 |
|
NDR2 protein kinase (STK38L)
|
|
22.222 (54/243) |
9.64E-07 |
|
Homeodomain interacting protein kinase 2 (HIPK2)
|
|
25.701 (55/214) |
1.18E-06 |
|
Guanine nucleotide exchange factor VAV2 (VAV2)
|
|
40.278 (29/72) |
1.27E-06 |
|
Endoplasmic reticulum to nucleus signaling 1 (ERN1)
|
|
26.786 (75/280) |
1.69E-06 |
|
GRB2-related adapter protein 2 (GRAP2)
|
|
44.643 (25/56) |
1.78E-06 |
|
Cyclin-dependent kinase 20 (CDK20)
|
|
27.670 (57/206) |
1.91E-06 |
|
MAPK signal-integrating kinase 1 (MKNK1)
|
|
25.670 (67/261) |
2.10E-06 |
|
Growth factor receptor-bound protein 2 (GRB2)
|
|
39.063 (25/64) |
2.73E-06 |
|
CDC-like kinase 2 (CLK2)
|
|
27.333 (41/150) |
3.01E-06 |
|
Casein kinase I gamma-3 (CSNK1G3)
|
|
26.259 (73/278) |
3.09E-06 |
|
Homeodomain-interacting protein kinase 1 (HIPK1)
|
|
23.636 (52/220) |
3.27E-06 |
|
Proto-oncogene vav (VAV1)
|
|
39.063 (25/64) |
3.49E-06 |
|
NDR1 protein kinase (STK38)
|
|
22.222 (54/243) |
1.10E-05 |
|
Tau-tubulin kinase 2 (TTBK2)
|
|
20.890 (61/292) |
1.22E-05 |
|
Signal transducing adapter molecule 2 (STAM2)
|
|
38.596 (22/57) |
1.31E-05 |
|
TBC domain-containing protein kinase-like protein (TBCK)
|
|
24.427 (64/262) |
1.45E-05 |
|
Ribosomal protein S6 kinase-like 1 (RPS6KL1)
|
|
29.299 (46/157) |
2.84E-05 |
|
Serine/threonine-protein kinase 40 (STK40)
|
|
24.022 (43/179) |
4.09E-05 |
|
Protein kinase C and casein kinase substrate in neurons protein 2 (PACSIN2)
|
|
35.185 (19/54) |
6.02E-05 |
|
Tribbles homolog 2 (TRIB2)
|
|
22.273 (49/220) |
7.21E-05 |
|
GRB2-related adapter protein (GRAP)
|
|
39.063 (25/64) |
8.70E-05 |
|
Homeodomain-interacting protein kinase 4 (HIPK4)
|
|
24.286 (51/210) |
1.18E-04 |
|
Rho guanine nucleotide exchange factor 7 (ARHGEF7)
|
|
38.596 (22/57) |
1.54E-04 |
|
Sugen kinase 110 (SBK3)
|
|
26.250 (42/160) |
1.70E-04 |
|
Unconventional myosin-Ie (MYO1E)
|
|
36.364 (20/55) |
2.71E-04 |
|
Serine/threonine-protein kinase SBK2 (SBK2)
|
|
31.532 (35/111) |
2.81E-04 |
|
NADPH oxidase activator 1 (NOXA1)
|
|
41.667 (25/60) |
3.69E-04 |
|
Ribosomal protein S6 kinase delta-1 (RPS6KC1)
|
|
26.829 (44/164) |
3.71E-04 |
|
Rho guanine nucleotide exchange factor 6 (ARHGEF6)
|
|
30.108 (28/93) |
4.17E-04 |
|
Tribbles homolog 1 (TRIB1)
|
|
22.652 (41/181) |
4.47E-04 |
|
Guanine nucleotide exchange factor VAV3 (VAV3)
|
|
40.351 (23/57) |
6.15E-04 |
|
SH3 and multiple ankyrin repeat domains protein 1 (SHANK1)
|
|
40.351 (23/57) |
6.97E-04 |
|
SH3 domain-containing YSC84-like protein 1 (SH3YL1)
|
|
36.364 (20/55) |
8.46E-04 |
|
SH3 domain-containing protein 19 (SH3D19)
|
|
32.258 (20/62) |
8.50E-04 |
|
Breast cancer anti-estrogen resistance protein 1 (BCAR1)
|
|
42.308 (22/52) |
1.00E-03 |
|
Hematopoietic lineage cell-specific protein (HCLS1)
|
|
38.182 (21/55) |
1.00E-03 |
|
Endophilin-A1 (SH3GL2)
|
|
34.375 (22/64) |
2.00E-03 |
|
Abl interactor 1 (ABI1)
|
|
30.588 (26/85) |
2.00E-03 |
|
Tribbles homolog 3 (TRIB3)
|
|
26.846 (40/149) |
3.00E-03 |
|
Epidermal growth factor receptor kinase substrate 8-like protein 3 (EPS8L3)
|
|
29.870 (23/77) |
3.00E-03 |
|
CDC7-related kinase (CDC7)
|
|
24.242 (40/165) |
3.00E-03 |
|
Eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4)
|
|
25.234 (27/107) |
3.00E-03 |
|
Neutrophil cytosol factor 2 (NCF2)
|
|
35.366 (29/82) |
3.00E-03 |
|
Dedicator of cytokinesis protein 5 (DOCK5)
|
|
31.343 (21/67) |
4.00E-03 |
|
Endophilin-A2 (SH3GL1)
|
|
34.921 (22/63) |
4.00E-03 |
|
Osteoclast-stimulating factor 1 (OSTF1)
|
|
34.426 (21/61) |
5.00E-03 |
| Click to Show/Hide the Information of Human Similarity Proteins |
